Oxtellar XR
Oxtellar XR is an extended-release formulation of oxcarbazepine, an antiseizure (anticonvulsant) medication. It is designed for once-daily dosing to help control and prevent partial-onset seizures by stabilizing hyperexcited nerve membranes in the brain.
Dosage by Body Weight
Must be taken once daily on an empty stomach, at least 1 hour before or 2 hours after a meal. Tablets must be swallowed whole and should not be crushed, chewed, or divided. Dosage should be titrated weekly based on clinical response and tolerability.
- Body Weight
- Below 5 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 6 years of age have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 6 years of age have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 6 years of age have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not indicated
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness in pediatric patients under 6 years of age have not been established.
- Body Weight
- 16-20 kg
- Dose
- 150 mg once daily
- Frequency
- Once daily
- Tracking Notes
- Only for pediatric patients aged 6 years and older. Pediatric starting dose is typically 8 to 10 mg/kg once daily (not to exceed 600 mg/day in the first week), titrated gradually.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not indicated | N/A | Safety and effectiveness in pediatric patients under 6 years of age have not been established. |
| 5-7 kg | Not indicated | N/A | Safety and effectiveness in pediatric patients under 6 years of age have not been established. |
| 8-10 kg | Not indicated | N/A | Safety and effectiveness in pediatric patients under 6 years of age have not been established. |
| 11-15 kg | Not indicated | N/A | Safety and effectiveness in pediatric patients under 6 years of age have not been established. |
| 16-20 kg | 150 mg once daily | Once daily | Only for pediatric patients aged 6 years and older. Pediatric starting dose is typically 8 to 10 mg/kg once daily (not to exceed 600 mg/day in the first week), titrated gradually. |
Formulation
Purpose
Treatment of partial-onset seizures in patients 6 years of age and older, used as either monotherapy or adjunctive therapy.
Generic Name
OxcarbazepineScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.